NCT03170674

CSD170501: Study to Assess Biomarkers of Tobacco Exposure in Smokers During In-Clinic Confinement Switch to an Electronic Cigarette

CSD170501: A Randomized, Controlled Study to Assess Biomarkers of Tobacco Exposure in Smokers During In-Clinic Confinement Switch to an Electronic Cigarette

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 114 (actual)
• Sponsor: RAI Services Company · Industry
• Sex: All
• Age: 21 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The purpose of this clinical study is to evaluate changes in biomarkers of exposure (BOE) to tobacco smoke constituents after smokers switch from combustible cigarettes to use of one of the three electronic cigarettes or abstinence.

Detailed description

This will be a two-center, randomized, controlled, switching, open-label, parallel cohort study. The study will compare biomarkers of tobacco exposure from subjects at baseline levels of biomarkers of tobacco exposure after they have switched to one of three electronic cigarettes or abstinence for 5 days.

Conditions

• Smoking

Interventions

Type	Name	Description
OTHER	FT21039	an electronic cigarette product
OTHER	FT21092	an electronic cigarette product
OTHER	FT21018	an electronic cigarette product

Timeline

• Start date: 2017-05-15
• Primary completion: 2017-08-18
• Completion: 2017-08-18
• First posted: 2017-05-31
• Last updated: 2017-09-08

Locations

2 sites across 1 country: United States